Psychometric properties of the treatment satisfaction with medicine questionnaire (SATMED-Q) in Indonesian patients with type 2 diabetes
International Journal of Pharmacy Practice · 2025
DOI: 10.1093/ijpp/riaf083 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmacy Practice, 2025. Verfasst von Nora Wulandari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Pharmaco-Therapy, -Epidemiology, and -Economics (PTEE), Faculty of Science and Engineering, University of Groningen, Antonius Deusinglaan 1, …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Patient Satisfaction. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Indonesian Education Scholarship, Center for Higher Education Funding and Assessment, Indonesia Endowment Funds for Education.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objectives
The Treatment Satisfaction with Medicine Questionnaire (SATMED-Q) is a valuable instrument for pharmacy practice research, but psychometric properties have not been investigated widely. Therefore, the aim of this study was to evaluate the psychometric properties of the Indonesian version of the SATMED-Q.
Methods
This was a cross-sectional study of patients with type 2 diabetes recruited from five community health centers in Indonesia. Participants completed the SATMED-Q, the Medication Adherence Report Scale (MARS-5), the 5 Level EuroQol 5 Dimensions (EQ-5D-5L) and the EuroQol Visual Analog Scale (EQ-VAS) instruments. Reliability and validity were tested. Key findings Overall, 486 patients (mean age 59 years old, 73.3% female) participated. Both internal reliability (Cronbach’s alpha 0.97) and test–retest reliability (intraclass correlation coefficient ranging from 0.615 to 1 across the domains) were high. Exploratory factor analysis supported the original six domain structure, with factor loadings exceeding 0.5. Confirmatory factor analysis showed a well-fitted model (comparative fit index = 0.968, Tucker-Lewis index = 0.958, standardized root mean square residual = 0.051, χ2/df = 3.652) and a moderate root mean square error of approximation value of 0.074. Convergent validity was demonstrated by a significant positive correlation between SATMED-Q and MARS-5 (r = 0.276) and EQ-VAS (r = 0.330).
Conclusions
The Indonesian SATMED-Q was found to be a valid and reliable instrument for assessing medication satisfaction as an important outcome to develop and evaluate pharmacy practice interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Pharmaco-Therapy, -Epidemiology, and -Economics (PTEE), Faculty of Science and Engineering, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
- Faculty of Pharmacy and Science, Universitas Muhammadiyah Prof. DR. HAMKA, Jl Delima II, Duren Sawit, Jakarta Timur 13460, Indonesia.
ORCID-Profile: Nora Wulandari
Förderung
- The Indonesian Education Scholarship
- Center for Higher Education Funding and Assessment
- Indonesia Endowment Funds for Education
Zitieren
APA
Wulandari, N., Balafas, S., Viviandhari, D., Nurhasnah, N., Jamilah, J., Feenstra, T., & Taxis, K. (2025). Psychometric properties of the treatment satisfaction with medicine questionnaire (SATMED-Q) in Indonesian patients with type 2 diabetes. International Journal of Pharmacy Practice. https://doi.org/10.1093/ijpp/riaf083
Vancouver
Wulandari N, Balafas S, Viviandhari D, Nurhasnah N, Jamilah J, Feenstra T, et al. Psychometric properties of the treatment satisfaction with medicine questionnaire (SATMED-Q) in Indonesian patients with type 2 diabetes. International Journal of Pharmacy Practice. 2025. doi:10.1093/ijpp/riaf083
BibTeX
@article{Wulandari2025,
author = {Wulandari, Nora and Balafas, Spyros and Viviandhari, Daniek and Nurhasnah, Nurhasnah and Jamilah, Jamilah and Feenstra, Talitha and Taxis, Katja},
title = {Psychometric properties of the treatment satisfaction with medicine questionnaire (SATMED-Q) in Indonesian patients with type 2 diabetes},
journal = {International Journal of Pharmacy Practice},
year = {2025},
doi = {10.1093/ijpp/riaf083}
}
EUVIMED